OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. The company was founded on July 4, 2007 and is headquartered in London, the United Kingdom.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. OKYO Pharma Limited - Ordinary Shares - New market cap is $73.47M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. OKYO Pharma Limited - Ordinary Shares - New 52 week high is $3.20 as of November 14, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. OKYO Pharma Limited - Ordinary Shares - New 52 week low is $1.20 as of November 14, 2026.
OKYO Pharma Limited - Ordinary Shares - New stock price today is $1.35.
OKYO Pharma Limited - Ordinary Shares - New stock price yesterday was $1.40.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. OKYO Pharma Limited - Ordinary Shares - New's P/E ratio is -7.09.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. OKYO Pharma Limited - Ordinary Shares - New P/B ratio is 5.7435.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. OKYO Pharma Limited - Ordinary Shares - New 50-day moving average is $1.41.
